Guideline Central Blog

Clinical Practice Guidelines

AHA 2024 Conference Preview - Hypertension

Hypertension Sessions at AHA24 – Conference Preview

The American Heart Association’s (AHA) annual meeting, AHA24 will take place from November 16–18, 2024 at the McCormick Place Convention Center in Chicago, Illinois. This event serves as the leading global platform for the latest advancements in cardiovascular science and medicine, offering attendees the opportunity to engage with cutting-edge research and practice-changing educational content. We […]

ACG 2024 Conference Recap- Inflammatory Bowel Disease (IBD)

ACG 2024 – Conference Recap on Inflammatory Bowel Disease (IBD)

The American College of Gastroenterology’s Annual Scientific Meeting and Postgraduate Course, ACG 2024, took place in Philadelphia, PA from October 25-30, 2024. This esteemed event was designed to address the educational needs and priorities of clinical GI practitioners, showcasing the latest advancements in clinical GI, hepatology, and endoscopy. During ACG 2024, several key abstracts were […]

Guidelines + Journal Rundown COPD

Top Chronic Obstructive Pulmonary Disease (COPD) Articles – Guidelines+ Journals Rundown

For COPD Awareness Month 2024, we will be taking a closer look at some of the most popular COPD articles recently published in the leading pulmonology journals. The Impact of Changing Race-Specific Equations for Lung Function Tests among Veterans with Chronic Obstructive Pulmonary Disease Impact of Dyspnea on Adults with Respiratory Symptoms Without a Defined […]

ACR 2024 Preview - Gout

ACR Convergence 2024 – Conference Preview on Gout

The American College of Rheumatology’s annual meeting, ACR Convergence 2024, is set to take place from November 14 to 19 at the Walter E. Washington Convention Center in Washington, DC. This event will bring together top experts in the field to share the latest advancements in rheumatology. To secure your spot at this prestigious event, […]

Upcoming FDA Approvals & Decisions

Upcoming FDA Decisions – November 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

ACAAI 2024 Conference Recap - Allergic Skin Conditions

ACAAI 2024 – Conference Recap on Allergic Skin Conditions

The Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology (ACAAI) was held in Boston, MA from October 24-28, 2024. This prestigious event provided a platform for esteemed thought leaders to share their expertise and innovative ideas, fostering discussions and collaborations that are essential for driving progress in the healthcare field. A […]

Guideline Timeline - VA/DoD’s Stroke Rehabilitation

VA/DoD’s Stroke Rehabilitation 2024 vs 2019 – Guidelines Timeline

In our most recent edition of the Guidelines Timelines, we will be exploring the topic of stroke rehabilitation. In August 2024, the Department of Veterans Affairs (VA) and the Department of Defense (DoD) jointly released an updated clinical practice guideline (CPG) for the management of stroke rehabilitation for their healthcare providers. This new guideline serves […]

USPSTF’s Screening for Intimate Partner Violence and Caregiver Abuse Recommendation is Now Open for Public Comment

The United States Preventive Services Task Force (USPSTF) recently released their draft recommendation statement titled “Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: Screening,” which was published online on October 29, 2024. In accordance with the latest screening guidelines, the USPSTF recommends that clinicians screen for intimate partner violence (IPV) in pregnant […]

Conference Recap (CNS 2024)

CNS 2024 – Conference Recap on Brain Tumors

The Cognitive Neuroscience Society (CNS) recently held its annual meeting, CNS 2024, from September 28th to October 2nd in Houston, Texas. This event provided attendees with the opportunity to delve into the latest advancements in neurosurgery and their impact on improving patient outcomes. The conference featured a lineup of distinguished speakers who delivered engaging and […]

Guidelines Rundown - HIV

Human Immunodeficiency Viruses (HIV) – Guidelines Rundown

Our Guidelines Rundown Series continues with a new article that explores the topic of Human Immunodeficiency Viruses (HIV). To offer guidance and support for clinical decision-making, several societies and organizations have released comprehensive guidelines that cover various aspects of HIV, including preventing and treating opportunistic infections in people living with HIV, the use of antiretroviral […]

Guidelines Timeline - ACG Alcohol-Associated Liver Disease

ACG’s Alcohol-Associated Liver Disease 2018 vs 2024 – Guidelines Timeline

In this installment of our Guidelines Timelines Series, we will be conducting a comparative analysis of the American College of Gastroenterology’s (ACG) 2024 guideline on Alcohol-Associated Liver Disease in contrast to their previous 2018 version. Alcohol-associated liver disease (ALD) stands as a prominent cause of preventable liver-related morbidity and mortality on a global scale, including […]

Guidelines + Journal Rundown Radiation Oncology

Top Radiation Oncology Articles – Guidelines+ Journals Rundown

In this post, we will be taking a closer look at some of the most popular radiation oncology-related articles recently published across medical journals. GEC-ESTRO Recommendations for Head & Neck Cancer Brachytherapy (Interventional Radiotherapy): 2nd Update With Focus on HDR and PDR Early-Stage Breast Cancer: A Critical Review of Current and Emerging Practice Clinical, Pathologic, […]

ACS Clinical Congress 2024 Conference Recap - Colon & Rectal Surgery

ACS Clinical Congress 2024 – Conference Recap on Colon and Rectal Surgery

The American College of Surgeons (ACS) hosted their Clinical Congress 2024 in San Francisco from October 19–22. This prestigious event provided a unique platform for education, networking, and exposure to cutting-edge surgical innovations that are shaping the field. Distinguished experts delivered a series of Named Lectures, covering a diverse range of topics within their respective […]

(MASCC) Int'l Guidelines

Multinational Association of Supportive Care in Cancer (MASCC) – Guidelines International Series

In this edition of our Guidelines International Series, we will be examining the guidelines from the Multinational Association of Supportive Care in Cancer (MASCC). MASCC is a global organization committed to advancing the practice, education, and research of supportive care in cancer. MASCC now includes members in over 70 countries around the world. With a […]

Guidelines Spotlight Advancing Genetic Testing in Kidney Diseases

Advancing Genetic Testing in Kidney Diseases – Guidelines Spotlight

In the United States, 37 million people suffer from chronic kidney disease, with 10% of adults and 70% of children affected by genetic causes. Despite advancements in genetic testing and a growing understanding of the genetic factors contributing to kidney diseases, genetic testing in nephrology lags behind other medical specialties. To address this gap, we […]

ASA 2024 Conference Recap - Pain Management & Anesthesia

Pain-Focused Sessions at ANESTHESIOLOGY 2024 – Conference Recap

The American Society of Anesthesiologists (ASA) recently hosted their annual meeting, ANESTHESIOLOGY 2024 (ANES), in Philadelphia, PA from October 18-22nd. This prestigious event offered attendees a unique opportunity to delve into cutting-edge ideas and innovations, achieve professional goals, and expand their network within the field of anesthesiology. ASA stands as a strong advocate for patients […]

Guideline Timeline - AHAASA Primary Stroke Prevention

AHA/ASA’s Primary Stroke Prevention 2024 vs 2014 – Guidelines Timeline

In this edition of our Guidelines Timeline series, we will explore the recently released 2024 Guideline for the Primary Prevention of Stroke by the American Heart Association (AHA) and American Stroke Association (ASA). This updated guideline supersedes the previous version from 2014, providing clinicians with a comprehensive resource to aid in the implementation of prevention […]

USPSTF Announces Breastfeeding Recommendation Statement is Now Open for Public Comment

The United States Preventive Services Task Force (USPSTF) has recently released their draft recommendation statement on breastfeeding interventions. The statement, titled “Breastfeeding: Behavioral Counseling Interventions,” was published online on October 22, 2024. According to the latest screening guidelines, the USPSTF recommends providing or referring pregnant and postpartum individuals to interventions that support breastfeeding. These recommendations […]

AACAP 2024 Conference Recap - Attention Deficit Hyperactivity Disorder (ADHD)

AACAP 2024 – Conference Recap on ADHD

The American Academy of Child and Adolescent Psychiatry (AACAP) Annual Meeting was held in Seattle, Washington from October 14-19, 2024. This prestigious event serves as the largest gathering of child and adolescent psychiatrists globally, providing a valuable opportunity to engage with and learn from peers and colleagues from over 60 countries. The AACAP 2024 Annual […]

Guidelines Rundown - Audiology Hearing Loss

Audiology / Hearing Loss – Guidelines Rundown (National Audiology Awareness Month 2024)

In honor of National Audiology Awareness Month 2024, our Guidelines Rundown Series will focus on the audiology/hearing loss related guidelines. Multiple societies have released comprehensive guidelines to provide guidance and support for clinical decision-making in the evaluation, diagnosis, and management of hearing loss in both adults and children. In this article, we will offer an […]

Vedolizumab (Entyvio/Takeda) – Guidelines+ Monographs

Welcome to the latest installment of our Guidelines+ Monographs Series. In this edition, we will delve into the medication vedolizumab, marketed under the brand name Entyvio by Takeda Pharmaceuticals. Entyvio is an integrin receptor antagonist indicated in adults for the treatment of moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn’s […]

Aripiprazole (Abilify Asimtufii/Otsuka) – Guidelines+ Monographs

Welcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication aripiprazole, marketed under the brand name Abilify Asimtufii by Otsuka Pharmaceutical Co., Ltd. Abilify Asimtufii (aripiprazole) is a long-acting injectable atypical antipsychotic for the treatment of schizophrenia and bipolar I disorder. It was initially approved in […]

Guidelines Spotlight Sport-Related Concussion (SRC)

Sport-Related Concussion (SRC) – Guidelines Spotlight

Sport-related concussion (SRC) is a prevalent injury in both recreational and organized sports. Over the past few decades, there has been significant advancement in our scientific comprehension of SRC, leading to the establishment of clinical recommendations for its diagnosis, assessment, and management. As the need for knowledgeable healthcare professionals to deliver evidence-based care for athletes […]

What's Changed Alopecia Areata

Alopecia Areata – What’s Changed

Alopecia areata is a prevalent autoimmune skin disease characterized by the development of patches of non-scarring hair loss. According to the National Alopecia Areata Foundation, nearly 7 million people in the United States (US) and 160 million worldwide are affected by alopecia areata or will be affected by it at some point. Currently, it is […]

Guidelines Side-By-Side Breast Cancer Screening

Comparing Breast Cancer Screening Guidelines – Guidelines Side-By-Side (Breast Cancer Awareness Month)

Among all women in the United States, breast cancer is the second most common cancer and the second leading cause of cancer-related deaths. In 2023, an estimated 43,170 women lost their lives to breast cancer. The incidence of breast cancer has been gradually increasing among women aged 40 to 49 years from 2000 to 2015, […]